Few data points exist for this record so far. The page fills in as further notices are published.
Supplier
Merck Healthcare Germany GmbH
Weiterstadt · DEU
Total awarded
—
0 / 0 with a value
Reg. Umsatzsteuer Ident Nr: DE264825399
Awards
| Awarded | Buyer | Winner | Contract value | Published |
|---|
| Cetuximab 500 mg in 0.1 l Lsg. Infusionslösung St a 100 ml | PBMG eG | Merck Healthcare Germany GmbH | — | 27 Feb 2026 |
| Fludrocortison 0,1 mg Tabletten St | PBMG eG | Merck Healthcare Germany GmbH | — | 27 Feb 2026 |
| Dexamethason 2 mg Tabletten St | PBMG eG | Merck Healthcare Germany GmbH | — | 27 Feb 2026 |
| Cladribin 10 mg Tabletten St | PBMG eG | Merck Healthcare Germany GmbH | — | 27 Feb 2026 |
| Avelumab 200 mg in 10 ml Konzentrat Infusionslösungskonzentrat St a 10 ml | PBMG eG | Merck Healthcare Germany GmbH | — | 27 Feb 2026 |
| Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Follitropin alfa, ATC G03GA05 für die Zeit 01.02.2024 - 31.01.2026 | DAK-Gesundheit | 1 4 U Pharma GmbH, 101 Carefarm GmbH, Abacus Medicine A/S, axicorp Pharma B.V., axicorp Pharma GmbH, CC Pharma GmbH, EMRA-MED Arzneimittel GmbH, EurimPharm Arzneimittel GmbH, Gedeon Richter Pharma GmbH, kohlpharma GmbH, Merck Healthcare Germany GmbH, Orifarm GmbH, Originalis B.V., Theramex Ireland Ltd. | — | 28 Jan 2026 |